These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33905283)

  • 1. The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics.
    Chaudhuri KR; Rukavina K; McConvey V; Antonini A; Lorenzl S; Bhidayasiri R; Piemonte MEP; Lim SY; Richfield E; Walker R; Bouca-Machado R; Bajwah S; Gao W; Trivedi D; Miyasaki J
    Expert Rev Neurother; 2021 Jun; 21(6):615-623. PubMed ID: 33905283
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care.
    Rukavina K; McConvey V; Ray Chaudhuri K; Miyasaki J
    Int Rev Neurobiol; 2022; 165():229-249. PubMed ID: 36208902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.
    Fabbri M; Leung C; Baille G; Béreau M; Brefel Courbon C; Castelnovo G; Carriere N; Damier P; Defebvre L; Doe de Maindreville A; Fluchere F; Fuzzatti M; Grabli D; Maltete D; Rousseau V; Sommet A A; Thalamas C; Thiriez C; Rascol O; Ory-Magne F
    Parkinsonism Relat Disord; 2021 Aug; 89():128-133. PubMed ID: 34293534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.
    Poonja S; Chaudhuri KR; Miyasaki JM
    Curr Opin Neurol; 2022 Aug; 35(4):494-501. PubMed ID: 35787539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on non-motor symptoms and Covid-19.
    Rota S; Boura I; Wan YM; Lazcano-Ocampo C; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():103-133. PubMed ID: 36208897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.
    Brooks SK; Weston D; Greenberg N
    Public Health; 2021 Oct; 199():77-86. PubMed ID: 34571441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of the COVID-19 Pandemic on Informal Caregivers of People With Parkinson's Disease Residing in the UK: A Qualitative Study.
    Rippon D; Hand A; Dismore L; Caiazza R
    J Geriatr Psychiatry Neurol; 2023 May; 36(3):233-245. PubMed ID: 36268777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic.
    Ketigian L; Piniella N; McGivney K; Lui S; Dukat A; Jung MK; Gallagher R; Leder A
    Front Public Health; 2021; 9():772805. PubMed ID: 35186865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease and Covid-19: The effect and use of telemedicine.
    Podlewska AM; van Wamelen DJ
    Int Rev Neurobiol; 2022; 165():263-281. PubMed ID: 36208904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life with Parkinson's Disease During the COVID-19 Pandemic: The Pressure Is "OFF".
    HØrmann Thomsen T; Wallerstedt SM; Winge K; Bergquist F
    J Parkinsons Dis; 2021; 11(2):491-495. PubMed ID: 33459663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stay mindfully active during the coronavirus pandemic: a feasibility study of mHealth-delivered mindfulness yoga program for people with Parkinson's disease.
    Kwok JYY; Lee JJ; Choi EPH; Chau PH; Auyeung M
    BMC Complement Med Ther; 2022 Feb; 22(1):37. PubMed ID: 35130894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease.
    McDaniels B; Subramanian I
    Int Rev Neurobiol; 2022; 165():197-227. PubMed ID: 36208901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.
    Macchi ZA; Ayele R; Dini M; Lamira J; Katz M; Pantilat SZ; Jones J; Kluger BM
    Palliat Med; 2021 Jul; 35(7):1258-1266. PubMed ID: 34006157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Covid-19 on research and training in Parkinson's disease.
    Wan YM; van Wamelen DJ; Lau YH; Rota S; Tan EK
    Int Rev Neurobiol; 2022; 165():283-305. PubMed ID: 36208905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients].
    Tezuka T; Osada T; Terayama Y; Kubota M; Okusa S; Shiihashi G; Kubo SI; Suzuki N; Nakahara J; Seki M
    Rinsho Shinkeigaku; 2022 Jan; 62(1):8-14. PubMed ID: 34924470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
    Bausewein C; Hodiamont F; Berges N; Ullrich A; Gerlach C; Oechsle K; Pauli B; Weber J; Stiel S; Schneider N; Krumm N; Rolke R; Gebel C; Jansky M; Nauck F; Wedding U; van Oorschot B; Roch C; Werner L; Fischer M; Schallenburger M; Reuters MC; Schwartz J; Neukirchen M; Gülay A; Maus K; Jaspers B; Radbruch L; Heckel M; Klinger I; Ostgathe C; Kriesen U; Junghanß C; Lehmann E; Gesell D; Gauder S; Boehlke C; Becker G; Pralong A; Strupp J; Leisse C; Schloesser K; Voltz R; Jung N; Simon ST;
    BMC Palliat Care; 2022 Jan; 21(1):10. PubMed ID: 35027041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease.
    Prasad S; Holla VV; Neeraja K; Surisetti BK; Kamble N; Yadav R; Pal PK
    Neurol India; 2020; 68(4):792-795. PubMed ID: 32859814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic.
    Song J; Ahn JH; Choi I; Mun JK; Cho JW; Youn J
    Parkinsonism Relat Disord; 2020 Nov; 80():148-151. PubMed ID: 33002722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.